Vyvanse

Vyvanse Official FDA information, side effects and uses.


AMRI Announces Second Quarter Results



TMCnet - ... to achieve anticipated revenues and earnings, costs related to the acquisition and any goodwill impairment related to such investments and acquisitions, the risks posed by international operations to the company, the commercial success of Vyvanse(TM ...

A slow year so far for innovative drugs
LabTechnologist.com - New River Pharmaceuticals' (now acquired by Shire) Vyvanse (lisdexamfetamine) for Attention Deficit Hyperactivity Disorder (ADHD); Tekturna (Aliskiren) from Novartis and Speedel, which treats hypertension; another high blood pressure drug from Gilead ...

Brokers' reports help offset housebuilder dip
Guardian Unlimited - JP Morgan said the company could underperform in terms of being able to successfully switch patients from Adderall XR, its attention deficit hyperactivity disorder treatment, to its new product Vyvanse. "There is real downside risk if Shire fails to ...